-
China Is Investigating Meta’s Acquisition of the AI Start-Ip Manus
Regulators said they would look at whether the deal for Manus, a Singapore start-up with Chinese roots, complied with China’s export and investment rules.
-
G.M. Books a $7.1 Billion Loss as It Scales Back E.V. Ambitions
General Motors said it was writing down the value of battery and electric vehicle factories after changes in federal policy undercut demand.
-
Polymarket Won’t Pay Users Who Bet on a U.S. Invasion of Venezuela
Polymarket users bet on whether the U.S. would invade Venezuela, but the prediction market said the Venezuelan president’s capture did not constitute an invasion.
-
Democratic lawmakers ask for an investigation of the Middle East envoy Steve Witkoff.
The request by a group of Congress members cites reporting by The Times and echoes a similar request by Democratic senators in September.
-
Federal Agents Shoot 2 in Portland, Ore., Police Say
The shootings in Portland, a city previously targeted by the Trump administration, come as Minneapolis grapples with a federal agent’s fatal shooting of a woman a day earlier.
-
U.S. Trade Deficit Fell to Lowest Level Since 2009 as Tariffs Reshape Trade
The monthly trade deficit continued to shrink in October after President Trump imposed sweeping tariffs on imports, the latest data showed.
-
The (Many) Wrinkles in Trump’s Vision for Venezuela
President Trump appears committed to laying claim to Venezuelan oil for a long time. But there are plenty of reasons for U.S. businesses to be wary.
-
Trump Sees AI’s Economic Promise, While Dismissing Potential Threats
The president said that artificial intelligence would create such an abundance of jobs that robots would be required to fill the gaps.
-
Senate Agrees to Display a Jan. 6 Plaque Honoring Officers
Federal law mandated that the memorial tablet be installed by March 2023, but Congress blew past that deadline.
-
Trump Backs Kennedy’s Moves on New Childhood Vaccine Schedule
In an interview with The New York Times, the president said that Health Secretary Robert F. Kennedy Jr. had not gone too far in his recommendations.